RESEARCH DOSSIER
Climate-Sensitive Disease Burden and Health Insurance Exposure
Abstract. Climate-sensitive disease constitutes an increasingly consequential dimension of health financing. Heat, infectious disease vectors, floodwater, wildfire smoke, storms, drought and associated interruptions of care can alter incidence, severity, treatment pathways, healthcare utilization, household financial exposure and the distribution of payer liabilities. The resulting burden is mediated by population composition, social vulnerability, insurance eligibility, benefit design, provider availability, adaptation, data quality and jurisdiction-specific institutions. This monograph develops a source-grounded international synthesis of climate-sensitive disease burden and health insurance exposure. It evaluates the causal distinctions between climatic hazard, meteorological event, anthropogenic contribution, attributable health outcome, paid medical claim and fiscal consequence; documents principal epidemiological and administrative evidence; establishes practical measurement and validation requirements; and analyzes the design of geographically responsive financing and care-continuity interventions. The key finding is that health-system adaptation and insurer financial exposure must be analyzed jointly at the level of a specified population, benefit package and provider market, rather than extrapolated from headline mortality or climate projections. Comparative case studies of commercial insurance, Medicare, Medicaid and different international financing structures show how the same physical hazard can generate different patterns of observed claims, suppressed care, deferred expenditure and public or private liability. The dossier presents algebraic illustrations that can be independently reproduced, identifies uncertainties in causal identification, and reaches source-bounded conclusions concerning risk projection, geographic adaptation, equity and supervisory governance. No proprietary theory, causal estimate from new data, or previously unreported empirical discovery is asserted.
Keywords: Climate-sensitive disease; health insurance exposure; climate change; heat-related morbidity; vector-borne disease; flood exposure; wildfire smoke; health insurance claims; medical expenditure; health risk projections; geographic adaptation; insurance affordability; risk adjustment; causal attribution; environmental epidemiology; health financing; climate resilience.
Introduction
Climate-sensitive disease burden denotes the incidence, prevalence, severity, disability and mortality of health conditions whose distributions vary with climatic conditions or climate-mediated environmental and social processes. Health insurance exposure denotes the portion of resulting medical and related financial obligations that attaches to an identified insurance or health-financing arrangement under its eligibility, benefits, payment and risk-sharing rules. These concepts connect epidemiology with financing. Their connection is contingent: a climate-related hospital admission may increase the paid claims of a commercial insurer, the spending of a public program, the out-of-pocket cost borne by a household, or a provider's uncompensated treatment, depending on the operative institutional contract.
The subject is international because disease geography and financing geography rarely coincide. Heat may increase risk in an urban insured population; dengue can intensify in areas served by publicly financed hospitals; flooding may block a rural treatment network; and the medical needs arising from displacement can cross the border of a plan, province or state. The IPCC health assessment examines interacting climate and non-climate determinants, including unequal vulnerability. The WHO climate-health fact sheet identifies direct physical events and indirect infectious, nutritional and health-system pathways. Both imply that population health impacts must be traced through locally specific mediators.
This monograph asks three questions. Which climatic exposures demonstrably affect morbidity, mortality and medical needs? Through which empirical and contractual steps do they affect covered utilization and insurer expenditure? Which geographic, institutional and preventive adaptations improve health protection without confusing short-term claim suppression with genuine risk reduction? The answers are built through critical comparison of authoritative assessments, peer-reviewed observational studies, official surveillance records and health-financing and supervisory materials. The inquiry does not infer personal insurance advice or set pricing for a particular insurer.
The research method distinguishes observed exposure–outcome associations, counterfactual climate attribution, prospective scenarios, descriptive administrative statistics and legal or professional guidance. A contemporaneous reported climate-health outcome is not automatically caused by anthropogenic climate change. Likewise, a paid medical claim is a filtered measure of disease, care seeking, service access, coding, reimbursement and enrollment. Maintaining these distinctions is the principal requirement for meaningful insurance interpretation.
Foundations and Source-Critical History
Formation of the research field
Research on weather and disease predates contemporary climate modeling, but standardized vital registration, longitudinal surveillance, distributed-lag models, health claims databases and coordinated assessments substantially expanded the field's evidentiary reach. An analytical milestone is Gasparrini and colleagues' multicountry temperature study, which estimated associations across 384 locations using location-specific time-series models and pooled results. Their estimated temperature-related mortality burden included cold and heat across the temperature distribution. The study showed why an exclusively extreme-heat definition leaves out consequential moderate exposures and why annual average temperature is a poor substitute for a locally calibrated exposure–response curve.
A later global modeling exercise by Zhao and colleagues (2021) estimated approximately 5.08 million deaths annually associated with nonoptimal temperatures over 2000–2019. The three-stage global burden study combined observed associations with extrapolation to geographic grids and estimated a larger cold-associated than heat-associated share for the period studied. These modeled associations concern temperature, including natural variability, and should not be repackaged as deaths caused by recent anthropogenic warming. Both studies have value for health services planning but their outcomes are mortality, while insurers primarily pay for defined treatment benefits and, in some arrangements, other covered health services.
Vicedo-Cabrera and colleagues (2021) used climate counterfactuals to distinguish heat mortality attributable to human-induced warming from heat-related mortality in the observed climate. Their anthropogenic heat attribution study estimated that 37.0% of warm-season heat-related deaths in the studied locations over 1991–2018 were attributable to anthropogenic climate change. The denominator is warm-season heat-related deaths in selected locations. It is neither a fraction of all worldwide deaths nor a fraction of insurance claims. The result underscores the difference between estimating the health response to actual temperature and attributing a portion of that temperature to changes in global climate.
The 2025 Lancet Countdown report expands monitoring across environmental hazards, adaptation, finance and health outcomes; its heat-related death estimate is an indicator constructed through modeling, with assumptions distinct from hospital billing. The World Health Organization's much-cited projection of about 250,000 additional deaths annually during 2030–2050 covers selected undernutrition, malaria, diarrheal disease and heat-stress pathways. The WHO projection's stated scope excludes numerous possible pathways and employs an older modeling baseline. Summing that figure with model-based contemporary mortality indicators would mix scenarios, dates and definitions and would double-count overlapping exposure mechanisms.
Core categories
A climate hazard is a potentially damaging physical process such as unusually high temperature or flooding. Exposure locates people and assets in relation to it. Susceptibility and vulnerability concern the conditional propensity to experience health harm after exposure, given physiological conditions, age, occupation, income, housing, services and protection. Disease burden encompasses deaths, disability and nonfatal episodes; medical utilization encompasses claims-bearing encounters, clinical services and related prescriptions. Provider capacity constrains whether illness generates observed treatment. Insurance exposure is the payable share after applying eligibility, covered services, payment rules and risk transfers.
These quantities can move in opposite directions. A flood may elevate underlying disease and temporarily close a clinic, reducing observed claims immediately; following restoration, deferred care can produce a surge. An insurer might observe lower measured outpatient spending during the period of worst health need, while an uninsured household experiences greater hardship. The distinction is essential for interpreting all claims-based studies discussed below. Estimates should state whether they measure population morbidity, service use, spending, plan-paid amounts, household expenditures or systemwide costs.
Hierarchy of evidence and scope of inference
Peer-reviewed empirical studies provide designs and uncertainty estimates, but country, time and population coverage constrain transferability. Official disease surveillance establishes reported cases subject to case-definition and ascertainment variation. Climate scenarios estimate alternative future physical states under stated assumptions. WHO and IPCC syntheses integrate evidence and identify confidence levels; their assessment judgments are not substitutes for a policy's benefit schedule. The WHO–World Bank UHC report supplies complementary indicators of access and financial hardship, which cannot be inferred from a medical payer's claims ledger.
A scientific account of insurance exposure therefore requires an explicit unit of analysis and a complete source chain. For each quantified claim, the author must record location, study years, exposure definition, age and eligibility, comparison group, outcome denominator, estimated effect, uncertainty interval and financing assignment. A study restricted to Medicare beneficiaries aged 65 or older cannot be generalized to all national health insurance populations without age standardization and institutional transportability assessment. Cost estimates denominated in a past currency year need transparent conversion before comparison with current paid amounts.
Heat, Vector, and Disaster Exposures
Heat, thermal physiology and chronic disease
Heat affects thermoregulation, hydration, renal function, cardiovascular load and respiratory vulnerability. The response to heat has both immediate and lagged components. Isolated heat-stroke diagnosis codes capture a narrower burden than heat-associated exacerbations of cardiac and respiratory disease. The CDC's heat-related illness indicators include emergency visits and hospitalization records; these administrative indicators depend on case classification and care access. The Heat & Health Tracker reports heat-related emergency department visits per 100,000 emergency department visits, an encounter-based denominator that differs fundamentally from member-months or population incidence.
An event-specific example is the CDC's 2026 emergency visit field report, which documented unusually high regional rates around a late-June to early-July U.S. heat episode. Such surveillance helps detect temporal clustering. It establishes neither all heat-related morbidity nor the fraction ultimately paid by insurers. Rates can rise because of a larger numerator, a changing total number of visits, a different facility mix, or changes in coding and detection. A valid insurer translation requires member denominators and benefit/payment joins.
The most directly insurance-relevant contemporary evidence is Romine and colleagues (2026), who connected 2016–2023 insurance claims with national heat-index observations across commercial, Medicaid and Medicare Advantage populations. Their claims-based heat-cost analysis linked an additional day at a heat index of at least 100°F during a week to greater emergency use and cost across nearly all assessed groups. Inpatient use was significantly higher in several specified coverage and age groups, while inpatient cost increases were not statistically significant for any coverage population. The correct inference is outcome-specific and payer-population-specific: evidence of increased utilization should not be translated mechanically into a statistically established increase in every spending category.
Heat effects differ by baseline local climate, urban surfaces, housing quality, labor exposure, access to cooling and existing illness. High nighttime temperatures can prevent physiological recovery; heat vulnerability may persist among people who spend little time outdoors if they lack cooling. Risks can be concentrated among outdoor workers and older adults, while childhood morbidity and pregnancy outcomes warrant distinct assessment. The IPCC health chapter emphasizes these moderating factors. Measurement should distinguish daily maximum, minimum, mean temperature, wet-bulb-related indices, apparent temperature and the chosen threshold, rather than silently treating them as interchangeable.
Vector-borne and waterborne disease
Vector-borne infection connects climate to temperature-dependent vector survival, replication, biting rates, rainfall and standing water. It also depends on pathogen introduction, housing, surveillance, prevention, travel and treatment. The WHO's 2026 global dengue update describes a surveillance system initiated in 2024 and reports approximately 2.2 million cases and more than 1,100 deaths across reporting locations during January–August 2026. These are reported disease counts from the designated window, not the counterfactual fraction caused by anthropogenic climate change. The 2026 counts should not be compared with full-year 2024 figures as though the observation periods were identical.
The European vector-disease observatory records the importance of regional establishment of competent mosquitoes, local conditions and surveillance. Expansion into a climate-suitable area generates potential transmission, but realized cases additionally require infectious introductions and contact networks. For health insurers, outbreak costs may involve laboratory testing, outpatient consultation, hospitalization for severe disease and care continuity across regions. No universal cost per reported dengue case can be inferred from global WHO surveillance; severity and payer responsibility vary markedly.
Malaria illustrates the danger of climate monocausality. The World malaria report 2025 documents a burden influenced by diagnosis, vector control, treatment coverage, drug resistance and population change. Malaria climate suitability may shift without a proportional change in realized cases if vaccination, preventive measures or treatment improve. Conversely, erosion of control capacity can increase burden without equivalent warming. An insurance model must represent intervention coverage and endemicity along with meteorological predictors; mapping climate suitability directly into medical claims is incomplete.
Storms and floods also alter pathogen exposures through contaminated water, disrupted sanitation and crowding, while post-event care shortages can conceal the clinical burden. The IPCC synthesis of waterborne risks supports attention to the combined exposure of environmental contamination and service disruption. These interacting mechanisms require separate disease indicators, with seasonality and post-event outbreak windows defined before examination of health claims.
Wildfire smoke and air quality
Wildfire smoke contributes fine particulate matter and other pollutants, exposing people far beyond the fire perimeter. The WHO wildfire health assessment distinguishes respiratory irritation, asthma exacerbation, cardiovascular consequences and acute outcomes. A smoke-related admission can occur in a jurisdiction with no insured fire loss. Thus a health insurer's geographic exposure map differs from a property insurer's burned-structure map: atmospheric transport, indoor filtration, preexisting illness and geographic patterns of coverage determine the relevant portfolio.
Vega and colleagues (2025) studied approximately 10.37 million older Medicare beneficiaries in the western United States during 2006–2016. Their wildfire hospitalization study reported a nonlinear exposure–response relationship for respiratory hospitalizations; the cardiovascular increase was not statistically significant. The distinction matters operationally. Respiratory planning may have a stronger evidenced claims pathway in that study than a generalized, equally quantified effect across all diagnosis categories. Moreover, smoke attribution depends on source apportionment; total PM2.5 pollution and wildfire-attributable PM2.5 are different measurements.
Ambient smoke concentration, indoor exposure, evacuation, use of respirators and access to air filtration affect realized dose. A health insurance intervention covering filtration or temporary respiratory services should be evaluated with measured access, utilization, clinical outcomes and expenditures, not simply with changes in atmospheric concentration. The area over which smoke travels and the time over which care is needed make static underwriting territories an incomplete unit of analysis.
Floods, hurricanes and interruption of care
Flooding combines injury, contaminated water, displaced residents, treatment interruptions and altered provider access. Wettstein and colleagues (2025) used a retrospective cohort of 11.8 million U.S. Medicare beneficiaries aged 65 or older in flood-exposed postal areas during 2008–2017. Their flood-associated medical cost study estimated increases of 4.8% in emergency visits and 7.4% in hospital admissions after flood exposure, and reported attributable national Medicare costs of approximately $69.3 million for emergency visits and $191.4 million for hospitalizations within the design. These figures are anchored to that study population, historical exposure events and its 2017-dollar cost standardization. They cannot be treated as an annual global insurance loss.
Disaster heterogeneity is evident in a seven-hurricane emergency utilization study, which found that overall visit rates changed little while respiratory and other cause-specific patterns shifted by age, proximity and time since landfall. An insurer focused only on aggregate encounters may miss an increase in acute medical need offset by fewer visits in other categories. A longitudinal hurricane provider study also documented persistent reductions in some health professional categories after Hurricane Katrina, with less pronounced effects after Hurricane Sandy. This supplies a distinct supply-side explanation for delayed claims and structural care loss.
Disaster effects extend beyond immediate injury. A Medicaid behavioral health claims study following the 2016 Baton Rouge-area flood found shifts in behavioral health utilization and associated costs in the identified population. The findings highlight prolonged mental health needs and the importance of tracking eligibility and enrollment changes. Trauma, displaced families and disrupted chronic-disease treatment can remain consequential after property reconstruction, and some of these costs emerge in medical or disability portfolios rather than catastrophe property claims.
Health Risk Projections and Insurance Mechanisms
From climate event to financed medical claim
A disciplined projection specifies a chain: climate scenario; local hazard distribution; individual exposure; health effect conditional on susceptibility and adaptation; care seeking; provider capacity; eligible services; payer shares; claim settlement; and ultimate financing. Every step changes the probability and timing of an insurer payment. A mortality model alone does not contain sufficient information to identify hospitalization costs. Nor does a patient-level claims sample identify population disease prevalence without information about uninsured people and untreated illness.
For a member i in period t, let A(i,k,t) indicate a covered treatment episode of mutually exclusive type k and let P(i,k,t) be its plan-paid amount. Expected covered expenditure is the sum over members and episode types of the product of each episode probability and its expected plan-paid amount, conditional on enrollment, health status, hazard, adaptation, benefit structure, provider network and payment conditions. This is an accounting expectation with standard probabilistic decomposition, not a newly proposed scientific model. If multiple claims belong to the same episode, they must be allocated without double counting before an episode-level calculation is interpreted as aggregate spending.
The climate-related incremental expected paid expenditure is the contrast between an identified future or historical world and a specified counterfactual climate, holding other choices constant or describing their alternative adjustment explicitly. Different policy questions require different contrasts: short-run additional spending with the same benefit design; the total burden under adaptive changes to coverage; or the financial incidence after reinsurance, risk equalization and public transfers. Comparisons must declare which quantities are endogenous. Replacing a baseline climate while also silently changing enrollment creates an uninterpretable estimand.
Exposure measurement and nonlinear risk
Distributed-lag epidemiological models acknowledge that heat, cold and pollution effects can occur over multiple days. The Gasparrini multicountry analysis demonstrates why local exposure–response relationships and delayed effects matter. A payer projection may translate epidemiological relative risks into additional events by combining a calibrated baseline event rate with the new exposure distribution, but must not transfer relative risks across age, disease, care delivery and geographic populations without assessment. A relative risk of 1.05 is a five percent change in a specified outcome rate under the study conditions, not a five percent increase in an insurer's entire portfolio expenditure.
Heat thresholds such as a heat index of 100°F, used in Romine and colleagues (2026), are directly relevant to that analysis but not necessarily optimal thresholds for every country. The insurer should assess extreme-value changes, duration, consecutive nights, humidity, seasonal acclimatization and local temperatures associated with minimum adverse outcomes. For multi-hazard scenarios, the same member may encounter heat and smoke or flood and infection in adjacent weeks; simple addition of hazard-specific cost projections can count the same admission twice.
The distinction between incidence, observed utilization and costs is equally relevant to changing healthcare prices. Actual claims costs reflect medical price inflation, provider contracts, coding practices, treatment technology and population aging, none of which is by definition caused by climate. Forecasts should report a physical-event component separately from a benefit, utilization, price and demographic component. When evidence is insufficient to isolate causal shares, scenario bands are preferable to false precision.
Insurance design, financial risk and risk pooling
Health insurance design redistributes exposure through premium pooling, community rating, public subsidies, employer contributions, deductibles, coinsurance, provider payment and eligibility rules. The OECD financing comparison distinguishes tax-supported schemes, compulsory health insurance and voluntary coverage. An increase in climate-related medical needs may appear as a higher insurer claims ratio, public budget requirement, provider cost, premium or household payment depending on these rules. This allocation requires an institutional ledger before any financial projection can be interpreted.
For a fully risk-rated voluntary plan, geographically correlated future morbidity can affect premium adequacy and risk selection. Under community rating or guaranteed issue, the immediate actuarial issue may be the risk-adjustment formula and subsidy distribution rather than neighborhood-specific rates. A tax-financed national service experiences provider workload and public expenditure without necessarily recording an insurance claim. The OECD comparison of population coverage shows that financing architectures vary even where core services are widely covered. Accordingly, international insurance comparisons must distinguish institutional expenditure from private insurer loss.
Exposure can be geographically correlated at multiple levels: households within a city, employer-sponsored insured groups working outdoors, elderly populations, or large areas sharing one provider network. Local concentration matters for short-term operational cash needs, medical capacity, pharmaceuticals, repricing and risk adjustment. It does not imply that a single catastrophe capital formula designed for property insurance should be transplanted to health insurance. Climate-sensitive medical exposure has a distinctive mix of chronic morbidity, repeat events, medical-cost inflation, care-delivery disruption and institutional redistribution.
Equity, affordability and financial protection
A payer's low claims ratio during a severe climate event may signal inability to seek care rather than favorable health outcomes. The 2025 UHC monitoring report reports progress and remaining gaps in service access and financial protection using revised indicators. The OECD coverage-depth analysis demonstrates why eligibility for core care and coverage of total costs must be assessed separately. Climate-related cost exposure thus has at least four perspectives: plan-paid amount, public payer obligation, out-of-pocket spending, and illness or forgone services that never appear as settled claims.
Useful equity measures include heat-related emergency encounters per 10,000 insured member-years, avoidable chronic-disease admissions, time to resumption of medications after flood exposure, unfilled prescriptions, vulnerable members living beyond travel thresholds of operating network facilities, and out-of-pocket liability by income group. Geographic models should report denominators for high-risk populations rather than treating claims volume as a proxy for fairness. Provider outages and displacement may selectively remove high-risk patients from claims records; analysis restricted to continuously enrolled persons can understate disruption in a changing population.
Geographic Insurance Adaptation
Territorial differentiation
The geographic unit should correspond to the hazard and the protection intervention. A heat-warning scheme may use small urban or neighborhood grids; flood care-continuity plans may use transportation networks and catchment areas; vector infection may require ecological zones and travel corridors; wildfire smoke may require dynamically modeled atmospheric plumes. Administrative borders, postal codes and insurance rating territories are convenient reporting units but are not physical risk boundaries. Spatial misalignment creates ecological bias when the average regional temperature of a policyholder address poorly represents workplace, indoor or travel exposure.
Geographic adaptation also requires accounting for population turnover. Displacement can move insured people into regions where plan networks are weak or out-of-network costs are higher. A shift in registered address after disaster may mechanically change geographic risk scores; a claims model that excludes displaced members because they leave an observation area can underestimate hardship. Preparedness must identify where the member can receive care, not simply where a previous contract was issued.
Prevention and continuity under insurance contracts
A feasible insurance response is the targeted mitigation of exposure plus a continuity pathway for clinically necessary treatment. Gould and colleagues' 2026 health insurance adaptation proposal discusses hazard-triggered access to cooling and filtration, and temporary relaxations that preserve early prescription refills or provider-network access during defined high-risk periods. The proposal is an analytical and policy framework. It should be evaluated as such; it does not establish the cost-effectiveness of each intervention in every market.
A public or private payer can test a hazard-triggered program prospectively with explicit eligibility, service window, coverage duration, user consent, clinical outcome measures, and claims follow-up. The counterfactual should be comparable high-risk members who did not receive the intervention or a defensible staggered roll-out. A reduction in claims costs without corresponding clinical improvement could indicate shifted treatment or reduced access. A reduction in avoidable admissions accompanied by maintained medication continuity provides more credible evidence of benefit. Intervention evaluation should include distributional outcomes because the cost of participating, including digital access, may differ sharply among vulnerable members.
Historical studies support the need for longer continuity windows. The Katrina and Sandy provider analysis reported geographic and disaster-specific persistence in provider availability. The Baton Rouge Medicaid study observed postflood behavioral-health needs over months. These outcomes imply that a uniform short disaster declaration window may be insufficient for care continuity when medical infrastructure remains impaired. Duration should depend on observed local service recovery and member needs.
Global financing diversity and implementation
In countries with public financing and limited private health insurance, adaptation may require budget stabilization, hospital resilience, disease control and emergency transport, with the government assuming most marginal costs. In mixed systems, cost incidence can be split among compulsory plans, voluntary supplementary insurers and households. In markets with weaker financial protection, insurers may cover relatively affluent populations while the highest disease burden lies outside insured membership. This creates a selection problem if national public health data are used as a direct projection of private claims. The WHO–World Bank financial protection findings and OECD financing typology are complementary, and both must be reconciled to the particular country and year.
Regions with rising dengue suitability need linked vector surveillance, community prevention, diagnostic capacity and benefit access. Regions affected by wildfire smoke need air-quality forecasts, respiratory medication continuity and continuity plans for older adults. Extreme-heat cities may need early warning systems, occupational protection, preventive outreach and medically appropriate cooling support. Floodplains may prioritize evacuation-compatible prescriptions, backup records, transport access and an expanded emergency provider network. Each action targets a documented causal pathway; the evidence base and financial responsibility differ across regions and schemes.
Regulation and governance
The International Association of Insurance Supervisors' 2025 climate supervision paper applies existing Insurance Core Principles to climate-related risks and supervisory practices. It is cross-jurisdictional guidance whose domestic effect depends on implementation. It supports structured governance, risk assessment, consumer protection and the documentation of uncertainty. Health-specific climate exposure governance should disclose the medical and benefit assumptions, coverage population, decision-maker, control owner, and the effects of geographic change on vulnerable consumers.
Climate projections should inform strategic stress testing rather than be mistaken for regulator-approved premiums. Separate near-term operational scenarios from multidecade disease and medical-spending scenarios; document scenario sources, time horizons, inflation assumptions and adaptation pathways. Insurers should compare provider continuity and affordable protection alongside capital adequacy. The institution that has authority to change benefits, and the legal basis for an emergency exception, must be identified for each jurisdiction. The IAIS paper cannot itself confer new contractual entitlements.
Data, Measurement, and Validation
Data architecture and denominator integrity
A defensible dataset connects climatic exposure to person-time at risk, documented health outcomes, care access, payment and jurisdiction. Core source families include gridded weather observations and reanalysis, local hazard warnings, vector and infectious surveillance, hospital encounters, insurer paid-claims databases, enrollment files, provider capacity inventories, census measures of deprivation and official financing rules. Each table requires a time stamp, spatial resolution, update frequency, event definition, version and access status. Insurance claims must preserve incurred date, adjudication date and paid date to assess lags and reporting delays.
For heat outcomes, the CDC syndromic tracker documentation makes the visit-based denominator explicit. If daily heat-related ED visits total 30 and all ED visits total 10,000, the displayed heat-specific share is 300 per 100,000 ED visits; it is not 300 visits per 100,000 residents or insured lives. To obtain a member-level rate, one must link a covered beneficiary population and exposure period to unique heat-associated episodes, accounting for repeat visits and enrollment. A single calendar-day census should not be used as annual person-time.
Disease surveillance is similarly conditional on testing and reporting practices. WHO's dengue surveillance update uses reports from participating countries and periods. Malaria figures from the WHO 2025 malaria report are derived with epidemiological estimation methods whose coverage differs from an insurer's diagnosis-coded claims. Both sources are valuable but require harmonization of underascertainment and case definitions. Spatial comparisons need a common time window, age structure, geographic coverage, and recording standard.
Identification, counterfactuals and errors
A climate-health association can be confounded by seasonal infections, long-term health trends, labor patterns, income, air pollution, wildfire smoke and healthcare system changes. Event-study methods, matched comparison regions, distributed-lag nonlinear models and difference-in-differences can be appropriate when their identifying assumptions are plausible. For example, a flood versus nonflood comparison must assess pre-event trends, migration, provider closures and changes in coding. The Medicare flood cohort study supplies a useful observational benchmark, but its results remain conditional on exposure classification and study design.
Counterfactual climate attribution is a second layer. The Vicedo-Cabrera anthropogenic analysis isolates a change in heat exposure attributable to warming under specified climate-model assumptions. Mapping its mortality findings into a claims forecast would additionally require age-specific morbidity relationships, service-use response and payer payment rules. Combining a long-run climate scenario with an independently projected secular trend in morbidity may double-count changes if both projections incorporate correlated population adaptation.
Measurement error appears in several forms: exposure misclassification from coarse geographic cells; missing heat illness codes; missed physician encounters during outages; survivorship bias; incomplete claims runout; changing diagnosis systems; and unstable beneficiary address records. Claims-based analyses should test exclusions for continuous enrollment, incorporate lagged paid-claim maturation and compare diagnoses and procedure codes over time. Prospective studies should register outcomes and avoid choosing thresholds solely because one historic threshold yields the desired insurer effect.
Evaluation metrics and robustness
Prediction quality should be measured both for health burden and financial consequences. Mortality and emergency visits require calibration, bias assessment, interval coverage and temporal out-of-sample performance. Claims models require member-level calibration, top-risk segment performance, reserve/runout sufficiency, sensitivity to reimbursement and robustness to changing enrollment. Geographic errors should be mapped, not averaged away. A model might predict nationwide annual costs accurately while missing citywide heat spikes that overwhelm the local hospital network.
Scenario analysis should report at least a reference climate, a warmer counterfactual, a warmer counterfactual with a specified adaptation measure, and a severe compound-hazard stress. For each, record the population, diseases, service classes, payer rules, price basis, capacity constraints and assumptions about movement. The resulting uncertainty interval may be wider than ordinary parameter sampling because climate-model, epidemiological transportability and policy uncertainties are structurally different.
The choice of outcome must reflect the question. For insurance solvency, one needs annual claims, liquidity and capital exposure at the relevant accounting level. For public health, one needs illness and disability, including unmet need. For equity, one needs access and out-of-pocket protection across groups. A single headline number conceals these differences. The OECD benefits and cost-sharing comparison provides an institutional rationale for outcome-specific measurement across countries.
Scientific reproducibility and source provenance
Every reported figure in this dossier is either attributed to a named evidence source with its original unit and period or identified as a hypothetical independent calculation. Global 250,000 future deaths, global modeled temperature-associated mortality, 37% warm-season anthropogenic-attributable heat mortality, and claims-based costs are different scientific quantities. None is used to estimate the others without an explicit model and compatible denominator. The references include the exact primary record checked. The evidence ledger documents claims and accessible verification level. No inaccessible commercial insurer microdata are represented as independently analyzed; no external academic peer review is claimed.
International Synthesis and Scientific Conclusions
Cross-system interpretation
The literature establishes physical pathways linking adverse climate conditions to health and clinical workload, with substantial heterogeneity in exposure, biology and social context. Insurance data provide an additional institutional view of those outcomes when individuals obtain billed care under eligible plans. The emerging evidence includes directly relevant medical claims analyses, notably Romine and colleagues (2026), and observational studies linking floods and smoke to utilization in specified public health insurance populations. These studies support climate-sensitive financial materiality in identifiable populations while preserving study-specific effect sizes and uncertainty.
Comparative interpretation requires distinguishing five levels: physical hazard, morbidity, available care, financed care and ultimately borne insurance liability. Each level has its own measurement processes and possible intervention points. Disease prevention reduces potential treatment needs, provider resilience preserves access, more extensive coverage can increase observed claims while improving protection, and reimbursement changes shift the financing incidence. These are interacting effects, so no inference about insurer financial performance can be made from observed mortality alone.
The practical significance of climate-sensitive morbidity differs across voluntary private insurance, compulsory multi-payer insurance and tax-funded systems. In voluntary plans, climate-correlated claims may be redistributed through rating and coverage selection, subject to law. In social insurance, risk equalization and subsidies may buffer territorial variation. In tax-financed systems, the public budget and provider infrastructure take a major share. International data imply different funding channels even when the same heat episode strikes populations with comparable biology. The OECD coverage classifications are a starting point for mapping those channels.
Original analytical synthesis
The original contribution of this dossier is the source-critical integration of climate attribution, administrative claims evidence and health-financing allocation into a common comparative reading. A climate-related death estimate, an infectious surveillance count and an incremental paid claim each answer a different question and belong to a different denominator. Existing research becomes actionable for insurer and public-payer governance when those denominators are preserved and linked through explicit mechanisms.
A second analytical conclusion concerns the interpretation of observed claims after catastrophe. An abrupt fall in encounters may reflect damaged provider capacity and loss of transport, not lower need. The hurricane ED utilization comparison and the post-hurricane provider evidence together motivate joint monitoring of claims and service capacity. In this interpretation, adequate insurance exposure analysis includes an unmet-need channel and a delayed-care channel beside the immediate payment channel. This is a substantiated reading of established evidence, not the establishment of a new doctrine or model.
A third conclusion concerns adaptation. Broad climate models are appropriate for stress testing, but short, geographically targeted interventions can be validated against observed outcomes within a particular health-financing system. The insurance adaptation policy analysis identifies practical responses, while medical claims data provide potential measurement. The decision standard is therefore an explicitly defined clinical outcome and financing incidence, with equity and service continuity reported in parallel.
Unresolved research agenda
Major unanswered questions concern the multi-year effect of repeated heat exposure on chronic care costs; the causal effects and distributional economics of insurer-supported cooling and filtration; the portability of benefit access during cross-border displacement; exposure under private insurance in middle- and low-income settings; spatial correlation between insurer enrollment and hospital service loss; and the treatment of compound hazards within medical expenditure projections. Data-sharing constraints, confidentiality, incomplete cross-payer claims and local legal differences impede uniform measurement.
Future investigations should use linked enrollment, climate and medical datasets with transparent governance, longitudinal follow-up, predeclared causal estimands and explicit sensitivity analysis. The research should test whether an adaptation reduces illness and hardship, not merely whether a payer observes smaller invoices. That distinction aligns the actuarial question with the public-health question while retaining an accurate account of how financial obligations are distributed.
Technical Appendix: Reproducible Exposure and Payer Examples
A simple episode-level accounting illustration
Consider a hypothetical, stable insured population of 100,000 members observed for one year. Suppose a specified climate exposure generates 200 additional, non-overlapping emergency-only episodes, each with an average allowed amount of $1,200, and 30 additional inpatient-only episodes, each with an average allowed amount of $16,000. This is an illustrative assumption, not a measured effect in the cited studies. The additional allowed cost is 200 × $1,200 + 30 × $16,000 = $240,000 + $480,000 = $720,000. On a per-member basis it is $7.20 annually, equivalent to $0.60 per member per month. If the plan bears an assumed 80% share of every allowed amount, its incremental expected payment is $576,000, or $5.76 per member annually and $0.48 per member per month, with the remaining $144,000 attributed to other payers or patient obligations. Real benefit design requires benefit-specific payment rules and limits rather than a universal 80% share.
If a genuinely effective intervention prevents one quarter of both episode categories, while episode costs and the insured population remain fixed, allowed additional cost falls to $540,000 and plan payment to $432,000, a $144,000 reduction in the plan-paid component relative to the first scenario. The intervention's economic merit cannot be determined until its program cost, distribution of prevented events, and patient outcomes are included. If the program itself costs $160,000 to the plan, the narrow one-year plan cash-flow comparison is $144,000 avoided claims minus $160,000 program cost, or -$16,000. Broader health and societal effects may remain favorable; measuring them requires additional evidence. This explicit arithmetic prevents conflating health benefit with immediate insurer cost saving.
Why surveillance rates cannot be used as claim incidence
Suppose 30 heat-related visits occur among 10,000 total emergency department visits during a surveillance period. The rate per 100,000 ED visits equals (30 / 10,000) × 100,000 = 300. Suppose the insured population separately contributed 12 of those visits over 20,000 member-days of exposure. Its crude encounter rate is (12 / 20,000) × 100,000 = 60 per 100,000 member-days. These rates differ in numerator linkage, denominator and observation period. Neither is an annual prevalence or a causal estimate. Repeated visits, enrollment changes and exposure history must be reconciled before comparisons with the CDC's official heat tracker rate.
Attribution, scenario and budget reconciliation
A descriptive time-series increase in annual claims equals a change in claims under all combined influences. A climate-attributable contrast requires an explicitly specified alternative climate and the same or a clearly defined alternative set of nonclimatic conditions. For an illustrative plan, annual medical expenditure can be written as the sum across mutually exclusive event types of frequency multiplied by mean plan-paid severity; changes in the aggregate can arise from frequency, unit price, mix, eligibility or coding. Product decomposition creates interaction terms; allocating all observed expenditure change to frequency, much less to climate, is a mathematical error.
For sensitivity analysis, repeat the accounting with low, reference and high plausible increments in climate-associated events; report medical price separately. If an event is followed by migration or temporary closure of a provider network, the rate of observed claims may fall while the underlying rate of illness remains high. A robust stress scenario therefore pairs expenditure with a service availability metric and a delayed claims runout assumption. Nothing in this illustration constitutes a forecast or endorsement of actuarial parameters.
Reproducibility controls
The sample calculations require only the declared numbers, multiplication and division. Monetary amounts are hypothetical U.S. dollars for mathematical clarity, without inflation adjustment or claim that they represent any country. The episode categories are mutually exclusive, avoiding the common double count of hospital admissions preceded by emergency visits. The example deliberately leaves reinsurance, administrative costs, medical inflation and program-specific benefit exclusions outside scope; adding them would require separately documented assumptions. Scientific claims in the substantive chapters instead use linked empirical literature and official institutional documents.
Conclusion
Climate-sensitive disease burden is already relevant to international health financing, and its insurance consequences are determined through identifiable steps connecting climate exposure, illness, access to care, coverage and payer payment. The evidence documents associations between heat and claims-bearing utilization, important flood-associated medical costs, smoke-related respiratory admissions and substantial regional differences in infectious disease suitability and surveillance. These findings support systematic exposure assessment, preventive care, robust disease and climate surveillance, and geographic care-continuity planning. Reliable financial estimates require locally calibrated epidemiology, eligibility and benefit data, patient and provider geography, price measurement, and transparent counterfactual assumptions. The strongest governance approach treats public-health outcomes, insurance payments, household financial protection and service continuity as separately observable but jointly consequential objectives. The conclusions follow from the cited established evidence and standard accounting logic and do not claim a newly instituted scientific theory.
References
World Health Organization (2023). Climate change and health. Fact sheet, October 12, 2023. https://www.who.int/en/news-room/fact-sheets/detail/climate-change-and-health
Cissé, G., McLeman, R., et al. (2022). Health, Wellbeing and the Changing Structure of Communities. In Climate Change 2022: Impacts, Adaptation and Vulnerability, IPCC Working Group II, Chapter 7. https://www.ipcc.ch/report/ar6/wg2/chapter/chapter-7/
Lancet Countdown (2025). The 2025 Report of the Lancet Countdown on Health and Climate Change: Climate change action offers a lifeline. Global report and indicator portal. https://lancetcountdown.org/2025-report/
Gasparrini, A., et al. (2015). Mortality risk attributable to high and low ambient temperature: a multicountry observational study. The Lancet 386(9991), 369–375. DOI: 10.1016/S0140-6736(14)62114-0. https://pubmed.ncbi.nlm.nih.gov/26003380/
Vicedo-Cabrera, A. M., et al. (2021). The burden of heat-related mortality attributable to recent human-induced climate change. Nature Climate Change 11, 492–500. DOI: 10.1038/s41558-021-01058-x. https://www.nature.com/articles/s41558-021-01058-x
Zhao, Q., et al. (2021). Global, regional, and national burden of mortality associated with non-optimal ambient temperatures from 2000 to 2019: a three-stage modelling study. The Lancet Planetary Health 5(7), e415–e425. DOI: 10.1016/S2542-5196(21)00081-4. https://pubmed.ncbi.nlm.nih.gov/34245712/
Romine, J., Liu, A., Cullen, D., Tang, K., Mattson, H., Talavera, M., Nazarian, A., Clarke, M., and Chi, W. C. (2026). Extreme Heat, Health Care Use, And Costs: Evidence From Commercial Insurance, Medicaid, And Medicare Advantage. Health Affairs, April 23, 2026. DOI: 10.1377/hlthaff.2025.01665. https://doi.org/10.1377/hlthaff.2025.01665
Gould, C. F., Tsou, A.-C., Puliady, S., and McMenamin, S. B. (2026). Health Insurance As Climate Adaptation: A Practical Framework. Health Affairs, May 4, 2026. DOI: 10.1377/hlthaff.2025.01670. https://doi.org/10.1377/hlthaff.2025.01670
Centers for Disease Control and Prevention (2024, current resource). Heat & Heat-related Illness. Environmental Public Health Tracking Program. https://www.cdc.gov/environmental-health-tracking/php/data-research/heat-heat-related-illness.html
Centers for Disease Control and Prevention (2026). Heat & Health Tracker. National Syndromic Surveillance Program. https://ephtracking.cdc.gov/Applications/heatTracker/
Vaidyanathan, A., Gates, A., Iniguez, P., Lee, J., and Bernstein, A. (2026). Notes from the Field: Heat-Related Emergency Department Visits—June 28–July 7, 2026. MMWR 75(36), 563–565. https://www.cdc.gov/mmwr/volumes/75/wr/mm7536a2.htm
World Health Organization (2025). World malaria report 2025: Addressing the threat of antimalarial drug resistance. Geneva: WHO. ISBN 9789240117822. https://www.who.int/publications/i/item/9789240117822
World Health Organization (2026). Global dengue update. Weekly Epidemiological Record 101(40), 285–289, October 9, 2026. https://www.who.int/publications/i/item/who-wer10140-285-289
European Environment Agency / European Climate and Health Observatory (accessed 2026). Vector-borne diseases. Climate-ADAPT. https://climate-adapt.eea.europa.eu/en/observatory/topics/health-impacts/infectious-diseases/vector-borne-diseases
World Health Organization (2026). Wildfires. WHO fact sheet. https://www.who.int/news-room/fact-sheets/detail/wildfires-and-health
Vega, S. L., Childs, M. L., Aggarwal, S., and Nethery, R. C. (2025). Wildfire Smoke Exposure and Cause-Specific Hospitalization in Older Adults. JAMA Network Open 8(4), e257956. DOI: 10.1001/jamanetworkopen.2025.7956. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2833326
Wettstein, Z. S., Parrish, C., Sabbatini, A. K., Rogers, M. H., Seto, E., and Hess, J. J. (2025). Emergency Care, Hospitalization Rates, and Floods. JAMA Network Open 8(3), e250371. DOI: 10.1001/jamanetworkopen.2025.0371. https://pubmed.ncbi.nlm.nih.gov/40063023/
Effects of Hurricanes on Emergency Department Utilization: An Analysis Across 7 US Storms (2020). Disaster Medicine and Public Health Preparedness, original journal record. https://pubmed.ncbi.nlm.nih.gov/33023692/
Long-term healthcare provider availability following large-scale hurricanes: A difference-in-differences study (2020). Original study record. https://pubmed.ncbi.nlm.nih.gov/33232383/
Medicaid Utilization Before and After a Natural Disaster in the 2016 Baton Rouge-Area Flood (2019). Original study record. https://pubmed.ncbi.nlm.nih.gov/31505136/
World Health Organization and World Bank (2025). Tracking Universal Health Coverage: 2025 Global Monitoring Report. Geneva: WHO. ISBN 9789240117808. https://www.who.int/publications/i/item/9789240117808/
Organisation for Economic Co-operation and Development (2025). Population coverage for healthcare. In Health at a Glance 2025: OECD Indicators. https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/population-coverage-for-healthcare_5c968b73.html
Organisation for Economic Co-operation and Development (2025). Health expenditure by financing scheme. In Health at a Glance 2025: OECD Indicators. https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/health-expenditure-by-financing-scheme_074bead0.html
Organisation for Economic Co-operation and Development (2025). Extent of healthcare coverage. In Health at a Glance 2025: OECD Indicators. https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/extent-of-healthcare-coverage_c55025dc.html
International Association of Insurance Supervisors (2025). Application Paper on the Supervision of Climate-related Risks in the Insurance Sector. Published April 16, 2025. https://www.iais.org/2025/04/iais-publishes-comprehensive-application-paper-on-the-supervision-of-climate-related-risks-in-the-insurance-sector/
Centers for Disease Control and Prevention (2026). CDC Heat & Health Tracker Uses NSSP Data. January 12, 2026. https://www.cdc.gov/nssp/php/partnerships/cdc-heat-health-tracker-uses-nssp-data.html